ED is closely associated with its comorbidities (hypertension, dyslipidemia and lower urinary tract symptoms (LUTS)). Therefore, several drugs have been prescribed simultaneously with PDE5 inhibitors. If a specific medication for ED comorbidities has enhancing effects on PDE5 inhibitors, it offers alternative combination therapy in nonresponders to monotherapy with PDE5 inhibitors and allows clinicians to treat ED and its comorbidities simultaneously. To establish theoretical basis of choosing an appropriate medication for ED and concomitant disease, we examined the effects combining a PDE5 inhibitor with representative drugs for hypertension, dyslipidemia and LUTS on relaxing the corpus cavernosum of rabbits using the organbath technique. The effect of mirodenafil on relaxing phenylephrine-induced cavernosal contractions was significantly enhanced by the presence of 10 À4 M losartan, 10 À6 M nifedipine, 10 À6 M amlodipine, 10 À7 M doxazosin and 10 À9 M tamsulosin (Po0.05). The maximum relaxation effects were 47.2 ± 3.8%, 57.6 ± 2.6%, 64.0 ± 3.7%, 76.1 ± 5.7% and 71.7 ± 5.4%, respectively. Enalapril and simvastatin had no enhancing effects. The relaxation induced by sodium nitroprusside alone (39.0±4.0%) was significantly enhanced in the presence of the 10 À4 M losartan (66.0 ± 6.0%, Po0.05). Tetraethylammonium (1 mM) significantly inhibited the enhancement effects of tamsulosin and doxazosin on mirodenafil-induced relaxation (doxazosin: 76.1 ± 5.7% vs 45.3 ± 2.3%; tamsulosin: 71.7±5.4% vs 48.1±3.5%). On the basis of these findings, losartan seemed to induce synergistic effects through an interaction with nitric oxide. In addition, K þ channel activation could be one of the mechanisms for the synergistic effect of combining mirodenafil with doxazosin or tamsulosin. We believe that the combination of a PDE5 inhibitor with losartan, nifedipine, amlodipine, doxazosin or tamsulosin could be a pharmacologic strategy for simultaneously treating ED and its comorbidities and increasing response rates to PDE5 inhibitors.
INTRODUCTION
ED is a common condition, with a reported prevalence of 52% in men aged 40--70 years in the United States 1 and 49% in men aged 50--80 years in Europe. 2 It can affect patients' lives in different ways, including disrupting interpersonal relationships, interfering with sexual life, causing problems with partners and increasing stress, all of which make ED a major quality of life issue. 3 ED has multifactorial causes and is associated with several chronic diseases, such as hypertension 4--7 dyslipidemia, 8 and lower urinary tract symptoms (LUTS).
2,9--13 Therefore, several drugs have been prescribed simultaneously with PDE5 inhibitors in ED patients. Several investigational and clinical reports have suggested that some types of medication, including antihypertensive drugs, alpha-adrenergic blockers and hypolipidemic agents, can help treat ED. In vitro studies examining alpha-adrenergic blockers, 14, 15 calcium channel blockers 16, 17 and angiotensin-converting enzyme inhibitors 18 have shown direct relaxation or induced increased relaxation in response to electrical field stimulation (EFS). Angiotensin receptor blockers have also been shown to improve sexual function 19--21 in clinical trials and have improved endothelial function in hypercholesterolemic rats. 22 Considering the aforementioned investigational and clinical reports, we hypothesized that combining a PDE5 inhibitor with antihypertensive drugs, alpha-adrenergic blockers or hypolipidemic agents might relax the corpus cavernosum synergistically. There is little information available in the literature concerning these issues. Therefore, we examined the effects of combining a PDE5 inhibitor with antihypertensive drugs, alpha-adrenergic blockers and hypolipidemic agents on the in vitro relaxation of the rabbit corpus cavernosum.
MATERIALS AND METHODS

Corporal tissue strip preparation
All animal experiments were conducted with the approval of the Institute for Animal Care and Use Committee of the Samsung Medical Center (Seoul, South Korea). Sexually mature male New Zealand white rabbits (2.2± 0.3 kg) were killed with an air embolism in the ear vein. Each entire penis was then surgically excised and cleaned by removing the corpus spongiosum and urethra. The corporal tissue was subsequently carefully dissected from the surrounding tunica. Three to four corporal strips of approximately equal size (2 Â 2 Â 10 mm) were obtained from each penis and were separately prepared for organ-bath studies. Each corporal strip was tied with silk in one organ chamber, with one end fixed to a tissue holder and the other secured to a force transducer. The latter was connected to an appropriately calibrated four-channel polygraph (PowerLab; ADInstruments, Sydney, NSW, Australia) in which the transducer output was recorded. The corporal strips were kept in the organ baths with Krebs solution maintained at 37 1C by a thermoregulated water circuit and by continuously bubbling with a mixture of 95% O 2 and 5% CO 2 . Each corporal strip was stretched to an optimal isometric tension of 1.0 g and was equilibrated for 90 min. During the equilibration period, the tissues were washed with fresh Krebs solution every 30 min, and the tension was adjusted if necessary.
Organ-bath studies in vitro
For antihypertensive drugs, we used losartan, an angiotensin II receptor antagonist that blocks the activation of angiotensin II AT 1 receptors, and enalapril, which inhibits the angiotensin-converting enzyme, a component of the blood pressure-regulating renin--angiotensin system. We also used nifedipine and amlodipine, which block the calcium channels in cardiac muscle and blood vessels. For LUTS, we used doxazosin and tamsulosin. Tamsulosin is a selective a 1 receptor antagonist that has preferential selectivity for the a 1A and a 1D receptors. Doxazosin is a non-selective a 1 receptor antagonist. Simvastatin was used as a class of drugs to lower the cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which has a central role in the production of cholesterol in the liver. Lastly, mirodenafil was used for PDE5 inhibitor and the receptor selectivity of mirodenafil is summarized in Table 1 . 23 In the first series of experiments, the following experiment was conducted to ascertain whether amlodipine, nifedipine, enalapril, doxazosin, tamsulosin or simvastatin enhanced mirodenafil-induced relaxation in the corpus cavernosum. The organ-bath concentrations have been decided based upon the human plasma level of each drug, and it was lower than the maximal plasma concentration of each drug (Table 2) . 24--31 Initially, the relaxation effect of mirodenafil was studied with a cumulative addition at concentrations ranging from 10 À9 to 10 À5 M, with a plateau of a 10 In the second series of experiments, to ascertain whether the synergetic relaxation effects of alpha-adrenergic blockers and mirodenafil were mediated through K þ channel activation, we investigated the response of mirodenafil (10 À5 M) on PE-induced tone after incubating the tissue with tamsulosin (10 À9 M) or doxazosin (10 À6 M) for 20 min. After three washes at 10 min intervals, the relaxation effects of mirodenafil (10 À5 M) were studied on PE-induced precontracted cavernosal strips of the corpus tissue exposed in the organ bath to 1 mM tetraethylammonium (TEA), a K þ channel inhibitor, for 40 min. We then incubated the tissue with tamsulosin (10 À9 M) or doxazosin (10 À6 M) for 20 min. Finally, we compared the relaxation magnitude of pre-and post-TEA incubation.
Lastly, the following experiment was conducted to confirm the direct effect of losartan on the corpus cavernosum. Control tissue strips were precontracted with PE, and cumulative response curves were constructed for sodium nitroprusside (SNP) (10 À9 to 10 À5 M). The tissues were then washed three times, followed by the addition of losartan (10 À5 M) to the organ bath for 20 min. The tissues were recontracted with PE, and cumulative response curves were again constructed for SNP. We then compared the relaxation magnitude of pre-and post-losartan incubation.
Solution and drugs
The Krebs solution had the following composition: NaCl, 118 mM l Mirodenafil and enalapril were provided by SK (Seoul, South Korea), and tamsulosin and doxazosin were provided by Astellas (Seoul, South Korea) and Pfizer (Seoul, South Korea), respectively. Simvastatin, amlodipine, losartan and nifedipine were obtained from Hanmi (Seoul, South Korea). The stock solutions of the drugs were prepared in dimethylsulfoxide, except for mirodenafil and losartan, which were dissolved in distilled water. The final concentration of dimethylsulfoxide was o0.1%, and this concentration did not affect the smooth muscle tone. All other chemicals were purchased from Sigma Chemical (St Louis, MO, USA). 
Statistical analysis
All data are expressed as means±s.e. of the mean, where n represents the number of strips. For the analysis, a paired t-test and a repeated measures analysis of variance were used, followed by the Bonferroni's post hoc test. P-values of 0.05 or lower were considered statistically significant. The values of the relaxation responses were given as a percent ratio of the level of tension at the maximal relaxation to the level of maximum contraction by PE.
RESULTS
Angiotensin receptor blocker
Losartan alone did not significantly affect the tone of the PEprecontracted tissues during consecutive experiments. Mirodenafil from 10 À9 to 10 À5 M induced a concentration-dependent relaxation of the PE-induced contraction of the cavernosal strips. The effect of mirodenafil on relaxing PE-induced cavernosal contractions was significantly enhanced by the presence of 10 À4 M losartan in the organ bath (Po0.05, Figure 1 , Table 3 ). The maximum effect was a 32.8 ± 2.0% inhibition of PE-induced contraction for mirodenafil alone vs 47.2±3.8% for the preincubation of 10 À4 M losartan (Po0.05). Other organ-bath studies of losartan were conducted to determine the losartan/nitric oxide (NO) interaction on corpus cavernous smooth muscle function because, in contrast to other drugs, only a few have verified the direct effect of losartan on corporal smooth muscle. Cumulative response curves constructed for SNP showed that tissue strip relaxation was significantly enhanced by losartan in six preparations (paired Student's t-test, Po0.05, Figure 1 ). The maximum responses to SNP (39.0 ± 4.0%) were significantly enhanced by the presence of losartan (66.0± 6.0%, Po0.05). Consequently, it was confirmed that losartan enhanced NO-induced relaxation in rabbit corpus cavernous smooth muscle relaxation. This could be one mechanism, in enhancing mirodenafil-induced relaxation.
Calcium channel blocker Nifedipine, an L-type calcium channel blocker, and amlodipine, an L-and N-type calcium channel blocker, did not significantly affect PE-induced contraction. Preincubation with nifedipine (10 À7 and 10 À6 M) enhanced the relaxation of mirodenafil significantly (Po0.05, Figure 2 ). The maximum effect was a 30.3±3.4% inhibition for the PE-induced contraction of mirodenafil vs 41.9 ± 1.7% for preincubation with 10 À7 M nifedipine (Po0.05) and 57.6 ± 2.6% for preincubation with 10 À6 M nifedipine (Po0.05). Preincubation with amlodipine also increased the relaxation of mirodenafil on PE-precontracted strips (Po0.05, Figure 2 , Table 3 ). The maximum À5 M losartan on rabbit cavernosal strips (n ¼ 6). The data are presented as the mean±s.e. of the mean. A repeated measures analysis of variance was followed by Bonferroni's post hoc test (a); paired t-test (b); *o0.05 compared with control; SNP: sodium nitroprusside. Table 3 . Effects of losartan, nifedipine, amlodipine, tamsulosin, doxazosin, enalapril and simvastatin on rabbit corpus cavernosum relaxations evoked by mirodenafil Alpha-adrenergic blocker Tamsulosin, a selective a 1A and a 1D receptor antagonist, and doxazosin, a nonselective alpha-receptor antagonist, did not significantly affect the tone of the PE-precontracted tissues during the consecutive experiment compared with controls. Preincubation with tamsulosin (10 À9 M) enhanced the relaxation effects of mirodenafil significantly (Po0.05, Figure 3 , Table 3 ). The maximum effect was 32.7 ± 7.6% inhibition of the PE-induced contraction of mirodenafil vs 71.7±5.4% for pre-incubation with 10 À9 M tamsulosin (Po0.05). Preincubation with doxazosin (10 À7 M) also enhanced the relaxation effects of mirodenafil significantly (Po0.05, Figure 3 ). The maximum effect was 32.1±7.2% inhibition of the PE-induced contraction with mirodenafil vs 76.1±5.7% for preincubation with 10 À7 M doxazosin. We investigated the role of K þ channel opening with respect to the synergistic effects of mirodenafil and alpha-adrenergic blockers because the K þ channel-opening effect has been described for alpha-adrenergic blockers 32 and PDE5 inhibitors. 33 As shown in Figure 4 , the nonspecific K þ channel blocker tetraethylammonium (1 mM, n ¼ 6, Po0.05) significantly inhibited the enhancement effect of tamsulosin and doxazosin on mirodenafilinduced relaxation. We suggest that K þ channel activation with alpha-adrenergic blockers and mirodenafil is one of the action mechanisms in this enhancing effect. Figure 3 . (a) The influence of tamsulosin on the relaxation induced by mirodenafil on PE-induced cavernosal contractions. The concentrationresponse curves of mirodenafil were performed in the presence of 10 À10 or 10 À9 M tamsulosin on rabbit cavernosal strips (n ¼ 6). (b) The influence of doxazosin on the relaxation induced by mirodenafil on PE-induced cavernosal contractions. The concentration-response curves of mirodenafil were performed in the presence of 10 À8 or 10 À7 M doxazosin on rabbit cavernosal strips (n ¼ 6). The data are presented as the mean ± s.e. of the mean. A repeated measures analysis of variance was followed by Bonferroni's post hoc test; *o0.05 compared with control. Table 3 ). Preincubation with 10 À6 M of simvastatin also did not significantly suppress the relaxation effects of mirodenafil.
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DISCUSSION
Several reports have suggested that medication for ED comorbidities (hypertension, LUTS and dyslipidemia) can help treat ED. In the acute application setting of an organ bath, alpha-adrenergic blockers and calcium channel blockers showed relaxation effects on the corpus cavernous. Contraction induced by 5-hydroxytryptamine was significantly impacted by doxazosin.
14 Nifedipine and verapamil, which are L-type calcium channel blockers, were effective in relaxing corpus cavernous smooth muscle induced by PE in vitro. 16--17 In the animal disease model, calcium channel blockers, angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers showed a re-establishment of ED. The spontaneous treatment of hypertensive rats with amlodipine or imidapril for 4 weeks induced a relaxation increase in the response to EFS of the corpus cavernosum. 18 Treating hypercholesterolemic rats with irbesartan also improved endothelial function. 22 In clinical trials, preliminary data from several randomized and open studies have suggested that angiotensin type 1 receptor antagonists may be associated with improvement in sexual function. 19--21 Although the effects of the aforementioned drugs on the corpus cavernosum have been addressed, only a few studies have focused on the possible enhancement interaction with PDE5 inhibitors. 34, 35 However, considering that approximately 30--40% of all ED patients do not respond to PDE5 inhibitors 36 and that many ED patients may take several drugs 37 for their comorbidities, this issue is important. The enhancing interaction with PDE5 inhibitors offers alternative combination therapy in nonresponders to monotherapy with PDE5 inhibitors and allows clinicians to treat ED and its comorbidities simultaneously.
Therefore, we evaluated the effects of the combined use of a PDE5 inhibitor and medication for ED comorbidities (for example, hypertension, LUTS and dyslipidemia). Losartan (10 À5 , 10
), amlodipine (10
), enalapril (10 À6 , 10 À5 M l --1 ) and simvastatin (10
À6
, 10 À5 M l --1 ) were not effective in relaxing PE-induced contractions in a rabbit corpus cavernosum if applied alone. However, losartan, nifedipine, amlodipine, tamsulosin and doxazosin, when applied in combination with mirodenafil, did potentiate mirodenafil-induced relaxation.
In clinical settings, this result would suggest that angiotensin receptor blockers or calcium channel blockers could be better options than other types of antihypertensive drugs if hypertensive patients need a PDE5 inhibitor for intercourse. Because there is a considerable population of patients with ED who do not respond to PDE5 inhibitors and because there is an increased prevalence of ED in patients with hypertension, the combination of a PDE5 inhibitor with an angiotensin receptor blocker or a calcium channel blocker could be a pharmacologic strategy to increase the response rates of ED patients with hypertension to PDE5 inhibitors.
The enhancing mechanism of angiotensin receptor blockers can be explained as follows. Recent data suggest that angiotensin II is produced and secreted by the human corpus cavernosum via adrenergic stimulation. Although the production of angiotensin II from angiotensin I is catalyzed by angiotensin-converting enzyme, other conversion pathways have been identied. 38 The degradation of angiotensin II by angiotensinase results in a peptide with a halflife of only a few seconds, 39 giving credence to the suggestion that the human corpus cavernosum is a local angiotensin II producing paracrine system. 40 This is supported by the ndings that human corpus cavernosum produces and secretes physiological amounts of angiotensin II, as much as 200fold greater than that in plasma, 41 and healthy men produce angiotensin II corpus cavernous blood levels that are higher during penile detumescence than tumescence. 39 Immunohistochemical staining of dog and rat corpus cavernous tissue revealed that angiotensin II-containing cells are distributed in endothelium and smooth muscle. 41 In addition, angiotensin II is secreted upon adrenergic stimulation by a variety of paracrine cells such as vascular endothelial cells, vascular smooth muscle cells, cardiocytes and granular cells of the juxtaglomerular apparatus. 42--44 As the human corpus cavernosum is considered a specialized vascular tissue, 39, 41 a similar stimulatory mechanism likely exists in the human penis. 40 EFS-induced relaxation of corpus cavernous strips was increased by 29.4% after exposure to guanethidine (inhibitors of the adrenergic pathway), atropine (inhibitors of the cholinergic pathway) and indomethacin (inhibitors of prostaglandin pathways) when values before and after losartan were compared. 40 The difference between EFS-induced relaxation of corpus cavernous strips before and after losartan administration was greater (140%) when guanethidine was omitted from the inhibitor À9 M tamsulosin on PE-induced cavernosal contractions (n ¼ 6). The data are presented as the mean ± s.e. of the mean; paired t-test; *a significant difference at Po0.05. TEA, tetraethylammonium.
cocktail. 40 Guanethidine-induced chemical sympathectomy made losartan less effective. This nding suggested angiotensin II released via adrenergic stimulation had been blocked by losartan.
In a previous study, angiotensin II caused a dose-dependent contraction of cavernous tissue through the activation of angiotensin type 1 receptors, and this contraction was blocked by the angiotensin type 1 receptor antagonist losartan. 40 Another recent study indicated that angiotensin II was a potent stimulator of the smooth-muscle enzyme NAD(P)H oxidase, which stimulates the production of reactive oxygen species, such as superoxide. 45 The interaction of superoxide with NO decreases NO bioavailability by promoting superoxide and generating the potent oxidative peroxynitrite radical, which is thought to have an important role in vascular pathophysiology. 46, 47 In this study, the relaxation of the rabbit corpus cavernosum PE-induced tone by SNP was significantly enhanced in the presence of losartan. A similar result has also been reported in recent studies using the human corpus cavernosum. 40 Therefore, it may be postulated that angiotensin II produced via adrenergic stimulation was blocked by losartan, inhibiting the decreased NO bioavailability effects of angiotensin II. Consequently, the effect of losartan on NO bioavaiability and its direct relaxing ability by blocking angiotensin II may be possible mechanisms for losartan-enhanced mirodenafil-induced relaxation.
Regarding the enhancing mechanism of calcium channel blockers, it has been reported that there are L-type voltage-gated calcium channels in the smooth muscle of the corpus cavernosum, and the contraction of this muscle and detumescence of the penis are highly dependent on an increase in the cytosolic concentration of Ca 2 þ . 48, 49 It has also been reported that 10 À5 and 10
nifedipine, an L-type calcium channel blocker, were effective in relaxing norepinephrine-induced contractions in the rabbit corpus cavernosum. 16 A recent study also reported that vardenafil and sildenafil possess direct muscle relaxant potential, possibly via inhibiting Ca 2 þ influx through both receptor-operated and voltage-dependent Ca 2 þ channels. 50 Therefore, we assumed that the collaborating effect of mirodenafil and nifedipine on Ca 2 þ modulation caused this enhancing effect. Amlodipine, which is an inhibitor of L-and N-type calcium channels, also had enhancing effects on mirodenafil in the present study. It seems that the enhancing effect of calcium channel blockers on mirodenafilinduced relaxation was not affected by receptor selectivity.
As for alpha-adrenergic blockers, several pilot studies have demonstrated that the combination of PDE5 inhibitors with this drug is more effective than monotherapy with PDE5 inhibitors in treating ED. 51, 52 In addition, a recent investigational study reported that the combination of alfuzosin and tadalal is more efficient than tadalafil alone in relaxing adrenergic tone in the human corpus cavernosum. And other investigational studies have demonstrated the enhancing effect of phentolamine with sildenafil. 34, 35 We analyzed the influence of the receptor selectivity of each alpha-adrenergic blocker on the enhancing effect with a PDE5 inhibitor. The predominant a1-adrenoceptor subtype is a1A in the human corpus cavernosum, 53 and the predominant a1-adrenoceptor subtype is a1B in the rabbit corpus cavernosum. 54 Therefore, we assumed that alpha-adrenergic blocker showed different effects on mirodenafil-induced relaxation, depending on their receptor affinity. However, in our study, doxazosin (a non-selective a 1 receptor antagonist) and tamsulosin (a 1A and a 1D receptor antagonists) showed equal enhancement of mirodenafil-induced relaxation. Although tamsulosin has a greater affinity for a 1A and a 1D receptors than other receptors, 55 it also has affinity for a 1B receptors, 56 thus explaining the lack of difference between doxazosin and tamsulosin in enhancing the effect of mirodenafil.
To ascertain this enhancing mechanism, we determined the role of K þ channel openings on the synergistic effects of mirodenafil and alpha-adrenergic blockers. It has been reported that sildenafil citrate is capable of producing cavernosal smooth-muscle relaxation by an additional mechanism that may involve a-receptors and K þ channel openings. 33 In addition, the K þ channel opening effect of phentolamine in the corpus cavernosum has been previously described. 32 In our study, TEA significantly inhibited the enhancement effect of tamsulosin and doxazosin on mirodenafilinduced relaxation. Thus, it may be hypothesized that the K þ channel-opening effect of mirodenafil and alpha-adrenergic blockers is one of the possible action mechanisms for enhancing the relaxation effect along with alpha-receptor blockage by mirodenafil and alpha-adrenergic blockers. In addition, effect of adrenergic blocker in increasing the efficacy of cyclic nucleotide-dependent vasodilation could be another enhancing mechanism. 34 In the present study, we also investigated the effects of an HMG Co-A reductase inhibitor and an angiotensin-converting enzyme inhibitor on mirodenafil-induced relaxation, both of which are among the most common drugs simultaneously prescribed with PDE5 inhibitors. The role of HMG Co-A reductase inhibitors in relation to RhoA prenylation in the pathophysiology of the spontaneously tonic smooth muscle has been investigated. 57 In a previous study, captopril directly enhanced endotheliumdependent relaxation in the rat aorta. 58 However, no enhancement or significant detrimental effects with mirodenafil were observed in our study.
In conclusion, the present study confirms that losartan, nifedipine, amlodipine, tamsulosin and doxazosin enhance mirodenafil-induced relaxation on PE-contracted corpus cavernosum of rabbits. We believe that these experimental data could be useful for choosing medications for chronic diseases in patients using PDE5 inhibitors.
